Everything below concerns Certificate of analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common for reference-grade material. |
| Solubility | Low in water | Dissolves in DMSO and some organic solvents. |
| Typical storage | -20 °C, desiccated | Protect from light and moisture. |
| Analytical method | LC-MS/MS | Used for trace detection in biological matrices. |
| Purity assessment | HPLC with UV detection | Often combined with NMR and mass spectrometry. |
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Melanocortin receptors are members of the rhodopsin family of 7-transmembrane G protein-coupled receptors. There are five known members of the melanocortin receptor system each with differing specificities for melanocortins:
== Life and career == He was born in Lambeth, London, the son of a railway agent, and followed his father into the same employer, as a clerk with the London and South Western Railway Company. He became a church organist and choir master, and joined an amateur operatic company, before he started entertaining on his own account at dinners, parties, smoking concerts, charity events and the like in the 1890s. Accompanying himself on the piano, he introduced topical patter and monologues into his act, and began to appear at music halls and concert halls in and around London. He became a professional entertainer around 1905, and performed regularly at St George's Hall under the management of John Nevil Maskelyne and David Devant. He toured Australia and New Zealand with Maskelyne and Devant's company in 1908, and was credited with much of the tour's success. On his return, billed as "Barclay Gammon and a Piano" and describing himself as a "Society Clown", he became increasingly successful with his patter and songs, most of which he wrote himself, and performed for some years at the Palace Theatre of Varieties.
==== Epitaxy ==== Epitaxial graphene growth on silicon carbide is a wafer-scale technique to produce graphene. Epitaxial graphene may be coupled to surfaces weakly enough (by the active valence electrons that create Van der Waals forces) to retain the two-dimensional electronic band structure of isolated graphene. A normal silicon wafer coated with a layer of germanium (Ge) dipped in dilute hydrofluoric acid strips the naturally forming germanium oxide groups, creating hydrogen-terminated germanium. CVD can coat that with graphene. The direct synthesis of graphene on insulator TiO2 with high-dielectric-constant (high-κ). A two-step CVD process is shown to grow graphene directly on TiO2 crystals or exfoliated TiO2 nanosheets without using any metal catalyst.
Sources: en.wikipedia.org
=== Synthesis === Tizanidine is a derivative of 2,1,3-benzothiadiazole and its first published synthesis was reported in a patent. The 5-chloro-2,1,3-benzothiadiazol-4-amine intermediate was a known compound, produced in three steps from 4-chlorophenylenediamine as shown. Treatment with two equivalents of thionyl chloride in pyridine formed the heterocycle, which was nitrated with sodium nitrate in sulfuric acid and reduced using iron and acetic acid.
=== Sericin === Sericin is a group of water-soluble proteins that coat the fibroin filaments and bind them together within the cocoon. In suture manufacture and most biomaterial processing it is removed during a step called degumming, in part because early studies associated it with inflammation and allergic reactions. That association has since been re-examined, and purified sericin is used in its own right—in coatings, gels, cosmetics and pharmaceuticals—for its capacity to retain moisture and its antioxidant activity. Recovering sericin from silk-processing wastewater also makes use of a material that would otherwise be discarded.
A revolution in nuclear strategic thought occurred with the introduction of the intercontinental ballistic missile (ICBM), which the Soviet Union first successfully tested in August 1957. In order to deliver a warhead to a target, a missile was much faster and more cost-effective than a bomber, and enjoyed a higher survivability due to the enormous difficulty of interception of the ICBMs (due to their high altitude and extreme speed). The Soviet Union could now afford to achieve nuclear parity with the United States in raw numbers, although for a time, they appeared to have chosen not to. Photos of Soviet missile sites set off a wave of panic in the U.S. military, something the launch of Sputnik would do for the American public a few months later. Politicians, notably then-U.S. Senator John F. Kennedy suggested that a "missile gap" existed between the Soviet Union and the United States. The US military gave missile development programs the highest national priority, and several spy aircraft and reconnaissance satellites were designed and deployed to observe Soviet progress. Early ICBMs and bombers were relatively inaccurate, which led to the concept of countervalue strikes — attacks directly on the enemy population, which would theoretically lead to a collapse of the enemy's will to fight. During the Cold War, the Soviet Union invested in extensive protected civilian infrastructure, such as large "nuclear-proof" bunkers and non-perishable food stores.
1903 – Simon Lake submarine Protector surfaced through ice off Newport, Rhode Island. 1930 – USS O-12 operated under ice near Spitsbergen. 1937 – Soviet submarine Krasnogvardeyets operated under ice in the Denmark Strait. 1941–45 – German U-boats operated under ice from the Barents Sea to the Laptev Sea. 1946 – USS Atule used upward-beamed fathometer in Operation Nanook in the Davis Strait. 1946–47 – USS Sennet used under-ice sonar in Operation High Jump in the Antarctic. 1947 – USS Boarfish used upward-beamed echo sounder under pack ice in the Chukchi Sea. 1948 – USS Carp developed techniques for making vertical ascents and descents through polynyas in the Chukchi Sea. 1952 – USS Redfish used an expanded upward-beamed sounder array in the Beaufort Sea. 1957 – USS Nautilus reached 87 degrees north near Spitsbergen. 3 August 1958 – Nautilus used an inertial navigation system to reach the North Pole. 17 March 1959 – USS Skate surfaced through the ice at the north pole. 1960 – USS Sargo transited 900 miles (1,400 km) under ice over the shallow (125 to 180 feet or 38 to 55 metres deep) Bering-Chukchi shelf. 1960 – USS Seadragon transited the Northwest Passage under ice. 1962 – Soviet November-class submarine K-3 Leninsky Komsomol reached the north pole. 1970 – USS Queenfish carried out an extensive undersea mapping survey of the Siberian continental shelf. 1971 – HMS Dreadnought reached the North Pole. USS Gurnard conducted three Polar Exercises: 1976 (with US actor Charlton Heston aboard); 1984 joint operations with USS Pintado; and 1990 joint exercises with USS Seahorse.
Sources: en.wikipedia.org
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.
Reference material is usually kept cold, dry, and protected from light. Frozen aliquots reduce repeated freeze-thaw cycles.
No approved pharmaceutical product exists, so manufacturing and quality controls are not standardized. Products may contain different compounds or impurities.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.